Author

T. Inzhelevskaya

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

M. S. Cragg· 2 shared A. Al-Shamkhani· 1 shared A. L. Tutt· 1 shared B. Frendeus· 1 shared C. H. Chan· 1 shared C. Penfold· 1 shared C. Richardson· 1 shared H. L. Smith· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. S. Cragg

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintJan 4, 2023

Synthetic STING agonists elicit powerful vaccine adjuvancy providing robust central memory and anti-tumour effects

L. D. Towner, L. N. Dahal, M. C. Taylor…·S. A. Beers

This study shows synthetic STING agonists enhance CD8+ T-cell responses, memory formation, and anti-tumour effects in mice, with implications for immunotherapy and vaccines.

DOI 10.1101/2023.01.04.522614

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivJun 29, 2020

Domain Binding and Isotype Dictate the Activity of Anti-human OX40 Antibodies

J. Griffiths, K. Hussain, H. L. Smith…·M. S. Cragg

This study evaluates how isotype and epitope of anti-human OX40 antibodies affect their therapeutic activity in tumor models.

DOI 10.1136/jitc-2020-001557

mouseexperimental assay

𝕏 PostBluesky